about
Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohortChanges in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs.Is antiretroviral therapy adherence substantially worse on weekends than weekdays?Food insecurity, neighborhood food access, and food assistance in Philadelphia.Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010Vasculitis in a cocaine userHIV-Related knowledge, attitudes, and practice among educated young adults in BotswanaPrescription monitoring programs and emergency department visits involving benzodiazepine misuse: Early evidence from 11 United States metropolitan areas.Availability of buprenorphine on the Internet for purchase without a prescription.Evidence-Based Care for People with Unhealthy Alcohol Use-Still Elusive.Prescription monitoring programs and emergency department visits involving opioids, 2004-2011.Hospitalization rates of people living with HIV in the United States, 2009.Insurance Coverage and Treatment Use Under the Affordable Care Act Among Adults With Mental and Substance Use Disorders.Physicians as a Source of Medications for Nonmedical Use: Comparison of Opioid Analgesic, Stimulant, and Sedative Use in a National Sample.High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic.Screening for homelessness among individuals initiating medication-assisted treatment for opioid use disorder in the Veterans Health Administration.Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance SurveyAssociation of chest radiographic abnormalities with tuberculosis disease in asymptomatic HIV-infected adults.Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study.Primary care physicians' perspectives on the prescription opioid epidemicUnderstanding Americans' views on opioid pain reliever abuse.Financial incentives to discontinue long-term benzodiazepine use: a discrete choice experiment investigating patient preferences and willingness to participate.For-profit treatment of opioid addiction.What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality--reply.Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.Delivery of screening and brief intervention for unhealthy alcohol use in an urban academic Federally Qualified Health Center.The emerging public discourse on state legalization of marijuana for recreational use in the US: Analysis of news media coverage, 2010-2014.Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain.Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs.Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey.Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program.Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013.Reducing the default dispense quantity for new opioid analgesic prescriptions: study protocol for a cluster randomised controlled trial.Closing the gaps in opioid use disorder research, policy and practice: conference proceedingsPayments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribingDeaths From Unintentional Injury, Homicide, and Suicide During or Within 1 Year of Pregnancy in PhiladelphiaPrimary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD)Early outcomes after implementation of treat all in Rwanda: an interrupted time series studyA new peptide ligand that targets particles and heterologous proteins to hepatocytes in vivoRacial discrimination in health care settings: does insurance matter?
P50
Q33417395-B381AA0B-DF5F-4B45-8DCC-A4851C50CBFDQ33684172-169554F9-3857-4307-BE3A-2F4301B0C37DQ33891127-B6123F33-7066-470D-A3A4-C715A50E106FQ34566798-10B7276D-EDE1-48E4-A245-79721588456AQ34664106-491AE6AF-4CBA-4B3B-AA9C-10C779334522Q35979742-2A227D62-9047-42B5-8ED8-B763E21299DAQ36488580-31AE3804-AABB-480C-9AEE-1BDA06A34213Q36577972-04EE4931-42C9-4A30-B389-F43E44BE0F05Q36692583-A74FB1D8-716C-4019-A006-EAC616A3905DQ37004530-C957EE34-B9FD-4EE6-9BA3-DBE3241F51E9Q37015810-FA7C5496-EF72-41BB-A347-FAA09EF1FA80Q37525293-B0727F2B-9E75-4133-A023-182C25BAF65DQ39017915-F4160061-48EE-47C2-A09C-10C33DDA2196Q39600758-66901982-DC99-4FBC-9CE6-6B1821158820Q40082158-2912787F-7651-4B41-AC07-309FC4F12FCEQ40147885-C081D9B3-E524-4CA0-8950-E80200F0C648Q40794905-90744C16-3B91-4308-96AF-184C83D9673CQ40797955-A5F4392B-04AC-4B24-837B-41A14635E56BQ41466490-C4F0E685-9493-4CD7-BB73-547F409FFEBEQ42105248-A685DFDE-296B-4A8A-A76F-0EBC6EF863AFQ42148213-C3E536FE-7D30-45BC-8220-C440F08F1F89Q42376780-64690B57-D0F2-4D42-8FD8-D8E097130C09Q44341878-70FEFD8B-D297-4459-AD55-34CDD21A4E25Q44350514-01D677BE-D867-4995-8F05-0DFB6961186DQ44350841-E077F23E-94EC-4848-A71C-8CA57A3C3AD2Q47141577-13F0F4FF-C03C-4C71-B4BC-2AA646529AA5Q47990122-89AE5B0E-DEC2-40C4-BB27-8DC774C27C66Q50025597-A2775B2D-B1F6-4A2E-924E-761EE0D3E4A4Q52606947-C815322D-9AF9-4AA8-A47A-5F6F83A9AF92Q52614298-592F5EB1-CB30-4FDA-BB33-981BCF74E48DQ52688468-8483CFC4-6744-49BA-915D-490044F7C157Q55059591-6E696FAF-D03B-416B-A718-3521F083AEE7Q55212239-4E96BDC9-62D3-4189-96E1-A25BD65BD60DQ59340637-C8C0E1E9-AC09-4521-BD61-3571EA6AE6DBQ60300862-4C78927B-94D2-40B2-A20B-C72C8D36F7B0Q62273354-56F2ED53-B4F4-44C5-9C3D-25524B9E6B59Q64072527-D6F6DED1-6C0F-4D8E-B1C2-9A9DB8288ED2Q64109407-876C09B9-7BDF-4997-A3B2-0356748A9F68Q79356147-118FD1B6-A284-4009-AA83-2A8313759EF0Q87111031-1AE3B015-EFF2-441E-8BA7-11B507D216C2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marcus A Bachhuber
@ast
Marcus A Bachhuber
@en
Marcus A Bachhuber
@es
Marcus A Bachhuber
@nl
Marcus A Bachhuber
@sl
type
label
Marcus A Bachhuber
@ast
Marcus A Bachhuber
@en
Marcus A Bachhuber
@es
Marcus A Bachhuber
@nl
Marcus A Bachhuber
@sl
prefLabel
Marcus A Bachhuber
@ast
Marcus A Bachhuber
@en
Marcus A Bachhuber
@es
Marcus A Bachhuber
@nl
Marcus A Bachhuber
@sl
P106
P21
P31
P496
0000-0002-5610-8382